Crosslinking Stabilized Target-Ligand Complexes for MALDI Mass Spectrometry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and analyzing intact, undigested, unfragmented supramolecular target-ligand complexes using mass spectrometry are limited by low sensitivity, laborious sample preparation, and the need for specific conditions, making them unsuitable for routine high-throughput analysis in biological applications.
Innovation Solution
The method involves crosslinking non-covalently bound target-ligand complexes with a crosslinking reagent to form covalently stabilized complexes, which are then analyzed using MALDI ToF mass spectrometry without digestion or fragmentation, enabling direct mass analysis and determination of binding affinity and interaction sites.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional mass spectrometry methods are used to analyze intact non-covalent complexes, then the analysis can be performed without digestion or fragmentation, but the sensitivity is low and signal intensity is weak due to instability of non-covalent complexes
Solution Approach 1:
The patent applies preliminary crosslinking action before mass spectrometry analysis to stabilize non-covalent complexes. By introducing a crosslinking reagent that covalently bonds target and ligand molecules prior to analysis, the complexes are rendered stable enough for reliable mass spectrometry detection, thereby resolving the contradiction between detecting intact complexes and maintaining their stability during analysis
2Measurement precision
If specific conditions such as special matrices solutions and soft laser analysis are used for MALDI MS, then intact non-covalent complexes can be detected, but the sample preparation becomes laborious and time-consuming
Solution Approach 1:
The patent changes the chemical state parameter of the complexes from non-covalent to covalent through crosslinking. This parameter change stabilizes the complexes and allows them to be analyzed under standard MALDI MS conditions without requiring specialized soft laser parameters or custom matrix solutions, thereby reducing preparation time while maintaining detection accuracy
3Measurement precision
If crosslinking is applied to stabilize complexes, then sensitivity and signal intensity improve, but the complexity of the analysis procedure increases
Solution Approach 1:
The patent introduces a crosslinking reagent as an intermediary substance that facilitates the stabilization of non-covalent complexes. This intermediary forms covalent bonds between target and ligand, thereby enhancing signal intensity and sensitivity. The crosslinking reagent acts as a mediator that simplifies the overall analysis by enabling the use of standard mass spectrometry procedures rather than requiring complex specialized protocols
4Loss of information
If intact ions from non-covalent complexes are analyzed directly, then the analysis reflects true binding interactions, but the throughput is limited due to low signal intensity and instability
Solution Approach 1:
The patent applies preliminary crosslinking to preserve the true binding interactions of non-covalent complexes. By crosslinking the complexes before analysis, the method maintains accurate binding information while simultaneously improving signal intensity and stability, thereby enabling higher throughput analysis without losing binding interaction data
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for high-sensitivity, accurate detection and analysis of intact ions from both purified and heterogeneous samples, facilitating applications in drug discovery, antibody characterization, and complexomics with improved throughput and ease of operation.
Implementation Method 1
contacting a non-covalently bonded, supramolecular target-ligand-complex with a crosslinking reagent to form a covalently stabilized supramolecular target-ligand-complex
Implementation Method 2
analyzing the intact ions from the covalently stabilized supramolecular target-ligand-complex by mass spectrometry
Implementation Method 3
analyzing the intact ions from the covalently stabilized supramolecular target-ligand-complex by mass spectrometry
Data Source
AI summary
Methods of using mass spectrometry and in particular matrix assisted laser desorption-ionization (MALDI) mass spectrometry to analyze, or otherwise detect the presence of or determine the identity of intact ions of undigested, unfragmented covalently stabilized supramolecular target-ligand-complexes, as well as the use of these methods in various biological application such as characterization of antibodies, drug discovery, and complexomics including automated or higher throughput applications.